🇺🇸 FDA
Patent

US 11046649

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

granted A61KA61K31/4184A61K31/423

Quick answer

US patent 11046649 (Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase) held by The Board of Regents of the University of Texas System expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/4184, A61K31/423, A61K31/4245, A61K31/428